Table 4.
OR | 95% CI | 95% CI | P-value | |
---|---|---|---|---|
Low | High | |||
Female versus male | 1.141 | 0.141 | 9.238 | 0.902 |
Age | 0.989 | 0.981 | 0.997 | 0.010 |
Clinical T stage | ||||
T1-2 | Ref | |||
T3-4 | 1.227 | 0.142 | 10.612 | 0.853 |
Clinical N stage | ||||
cN− | Ref | |||
cN + | 0.693 | 0.180 | 2.675 | 0.595 |
Histological grade | ||||
I | Ref | |||
II | 1.989 | 1.191 | 3.320 | 0.009 |
III | 4.623 | 2.743 | 7.793 | < 0.001 |
Subtype according to IHC | ||||
Luminal | Ref | |||
HER2-positive | 2.774 | 2.134 | 3.607 | < 0.001 |
Triple-negative | 1.046 | 0.753 | 1.451 | 0.790 |
The multivariate models were complete case analyses
Bold text indicates a statistically significant difference with a p-value less than 0.05